{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:40:19Z","timestamp":1791312019429,"version":"4.3.1"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["LUTS"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Nocturia is considered a clinical problem when nocturnal urinary frequency is two or more times. For affected patients, development of depression, falling, and increased mortality rate are matters of concern. The present study investigated the efficacy and safety of lemborexant for insomnia patients with nocturia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Insomnia patients (Athens Insomnia Scale [AIS] \u2265\u20096) who typically awoke twice or more during the night to urinate and were examined at our institutions from June 2021 to December 2022 were enrolled. Each was administrated 5\u2009mg of lemborexant, one tablet, daily for 4\u2009weeks. Total AIS score, nocturia frequency, individual frequency\u2010volume chart findings, and N\u2010QOL score were examined before and after administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 37 patients recruited, 5 were excluded, thus 32 were enrolled and subjected to analyses. Following lemborexant therapy, the mean AIS total score was significantly decreased from 11.4 to 7.8 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) as was mean number of nocturia episodes from 3.4 to 2.3 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Furthermore, the mean single voided urine volume at night was significantly increased from 182.5 to 225.3\u2009mL (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001)and mean period of undisturbed sleep was significantly extended from 105.3 to 174.8\u2009min (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), while mean total N\u2010QOL score was significantly improved from 49.6% to 64.8% (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). As for adverse events, mild somnolence was observed in three cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Lemborexant may be effective and safe for use in insomniac patients with nocturia.<\/jats:p><\/jats:sec>","DOI":"10.1111\/luts.12534","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T01:34:17Z","timestamp":1728610457000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of Lemborexant for Insomnia Patients With Nocturia\u2014A Prospective Study"],"prefix":"10.1111","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4192-7198","authenticated-orcid":false,"given":"Yoshikazu","family":"Togo","sequence":"first","affiliation":[{"name":"Department of Urology Kawanishi City Medical Center  Hyogo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kaizuka","sequence":"additional","affiliation":[{"name":"Department of Urology Kawanishi City Medical Center  Hyogo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Urology Kawanishi City Medical Center  Hyogo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kajio","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine Kyoritsu Kinen Hospital  Hyogo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Kondoh","sequence":"additional","affiliation":[{"name":"Department of Urology Kawanishi City Medical Center  Hyogo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Taguchi Urology Clinic  Hyogo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.10052"},{"key":"e_1_2_9_3_1","first-page":"266","article-title":"Epidemiologic Survey on Urination","volume":"14","author":"Homma Y.","year":"2003","journal-title":"Journal of Japan Neurogenic Bladder Society"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13791"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.05.093"},{"key":"e_1_2_9_6_1","volume-title":"Clinical Guidelines for Nocturia","author":"The Committee for Establishment of the Clinical Guidelines for Nocturia of the Neurogenic Bladder Society","year":"2007"},{"key":"e_1_2_9_7_1","volume-title":"The Japanese Guidelines for Appropriate Use and Withdrawal of Hypnotics","author":"Mishima K.","year":"2014"},{"key":"e_1_2_9_8_1","volume-title":"Guidelines for the Treatment of Nocturia","author":"Japanese Society of Urinary Function and the Japanese Urological Association","year":"2020"},{"key":"e_1_2_9_9_1","first-page":"1543","article-title":"A Study on the Efficacy of Eszopiclon in Patients With Insomnia and Nocturia","volume":"28","author":"Nishimoto M.","year":"2015","journal-title":"Japanese Journal of Urological Surgery"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1757-5672.2012.00166.x"},{"key":"e_1_2_9_11_1","first-page":"17","article-title":"Efficay and Safety of the Orexin Receptor Antagonist for Patients With Both Insomnia and Nocturia","volume":"81","author":"Suetomi T.","year":"2019","journal-title":"Nishinihon Journal of Urology"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12073"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(02)00604-9"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2011.06.010"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211039098"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eursup.2005.07.002"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13383"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000506489"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaa123"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.18254"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8294"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000703500513"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-13-30"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-022-05232-3"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13877"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20210471"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.08.040"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2009.07.025"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.10.019"},{"key":"e_1_2_9_30_1","first-page":"317","article-title":"Development and Linguistic Validation of the Japanese Version of the Nocturia Quality of Life Questionnaire (N\u2010QOL)","volume":"20","author":"Yoshida M.","year":"2009","journal-title":"Journal of Japan Neurogenic Bladder Society"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1544"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.05.025"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2020.1823724"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13619"}],"container-title":["LUTS: Lower Urinary Tract Symptoms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/luts.12534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T01:28:30Z","timestamp":1732670910000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/luts.12534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1111\/luts.12534"],"URL":"https:\/\/doi.org\/10.1111\/luts.12534","archive":["Portico"],"relation":{},"ISSN":["1757-5664","1757-5672"],"issn-type":[{"value":"1757-5664","type":"print"},{"value":"1757-5672","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"2024-06-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e12534"}}